We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.50 | 0.28% | 1,640.50 | 1,640.00 | 1,640.50 | 1,656.00 | 1,635.00 | 1,642.00 | 5,918,777 | 16:29:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.71 | 67.54B |
Date | Subject | Author | Discuss |
---|---|---|---|
08/10/2016 12:12 | Dividend pays out on Thursday, but I don't think I'll be buying more with it at these prices ...... | tradermichael | |
07/10/2016 14:18 | Inverse H&S anyone - target 1800? | toffeeman | |
07/10/2016 14:15 | PHILO, I guess that looks good now. Will it still look as good when you retire? Or are you making hay while the dollar shines? | solomon | |
07/10/2016 13:34 | More than half my sip is denominated in $. | philo124 | |
07/10/2016 13:20 | £1 = $1.23 ...... wow | tradermichael | |
07/10/2016 08:17 | I'll buy back in if the price falls and for now I'm looking for 1750p to sell the balance of my current holding .............. ;0) | tradermichael | |
06/10/2016 20:14 | TM you going to sell again at 1700p? | philo124 | |
06/10/2016 16:28 | But right now, the £ has really weakened against the dollar. At $1.26, I am surprised GSK price hasn't raced past 1700p | tradermichael | |
06/10/2016 11:51 | The eternal question - when, because at some point rates surely will normalise.And when they do, it's curtains given the debt burden. Simply unserviceable. | fangorn2 | |
06/10/2016 11:48 | It might help a bit. The subject of leverage is complex because without it difficult to make serious profits. The risk today is when interest rates revert to some normality and it forces repayment of debt. | alphorn | |
06/10/2016 11:42 | @Alphorn, Agree to some extent..but surely the worst offenders, the big banks/hedgies wouldn't bat an eyelid at marginal rise in such rates? | fangorn2 | |
06/10/2016 11:41 | Fangorn - if margin requirements were raised it would sort out a lot of the 'spivs'. | alphorn | |
06/10/2016 11:38 | @Alphorn, Yes I'm aware of their "hedging" uses, but lookin at the City - majority of derivatives are seemingly used to PUNT. Eg Credit Derivatives - a useful tool to hedge loan/bond exposure (or, as the case turned out, take massive syntrhetic punts on credit worthiness of asovereigns/corproat ie Spivdom. City is now primarily a casino. Mortgages are a different kettle of fish(Unless they're low grade, packaged into a MBO/CDO structure and then spivily sold as triple A... :) Yes, big fan of GSK myself, drugs, divi, diversified biz, defensive | fangorn2 | |
06/10/2016 09:03 | Fangorn - not all derivatives are leverage, they can be used for many reasons. It is when leverage gets out of hand that is the problem. Same for a mortgage, that is leverage too! I am a great Glaxo fan for various reasons including their amazing drugs. | alphorn | |
06/10/2016 08:25 | Alphorn, Called spivdom - use of derivatives, and synthetics to take leveraged positions to exacerbate moves. As an aside, I see the technical picture for Glaxo is such that £19 is apparently possibly on the cards!! Zak Mir rooting for Glaxo!! [...] www.proactiveinvesto | fangorn2 | |
05/10/2016 20:46 | Called supply and demand as for any other asset class. | alphorn | |
05/10/2016 14:03 | Cable will fall as far as the "Spivs" want it to.....all rather preditable. | fangorn2 | |
05/10/2016 08:03 | It would be nice if it did push the price substantially over 1700p. How much further can the pound fall, given the news of our strong economy? ..... ;o) | tradermichael | |
04/10/2016 09:29 | Sterlings fall helping push us back to 1700 again. | tim 3 | |
02/10/2016 11:33 | Sunday Times today, we may be on the cusp of a cure for HIV. Project between the NHS and some UK universities. Development will take a number of years. | essentialinvestor | |
28/9/2016 09:16 | Agree reference options being an exception. | tim 3 | |
28/9/2016 08:32 | tim - agree, unless you are an option trader when being 'long' and 'short' at the same time (strangles or straddles) is your strategy on a particular share to pull in both premiums/premia. Covered calls would also fit your description, both in equities and forex. Can give high yields with nothing to do with deferring a loss. | alphorn | |
27/9/2016 22:01 | Correct about risk management and trading. For example most uneducated traders have no idea how difficult it is mentally to close a losing trade it goes against every human instinct and this results in poor trading.I see it all the time on the boards adding to losing positions long and short at the same time anything to avoid taking a loss. In The excellent Disciplined Trader by Douglas he explains this in great detail. | tim 3 | |
27/9/2016 14:58 | Whose Drug Pipeline Impresses Most? A Rough Comparison Of GlaxoSmithKline And AstraZeneca | fangorn2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions